Laurion Capital Management’s Q32 Bio QTTB Stock Holding History

Laurion Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,869	Closed	-$1.01M	–	1330
2019 Q2	$1.01M	Buy	+2,869	New	+$1.13M	0.01%	562

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Laurion Capital Management's QTTB Position: Q3 2019 in Review

Laurion Capital Management sold out of Q32 Bio (QTTB) in Q3 2019, closing a stake of 2,869 shares — an estimated $1.01M sold.

Laurion Capital Management first reported a position in QTTB in Q2 2019 and held it in 1 quarter. The position peaked at $1.01M in Q2 2019. 80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

Laurion Capital Management reported no remaining Q32 Bio position as of Q3 2019 after selling out during the quarter.
Laurion Capital Management sold 2,869 Q32 Bio shares in Q3 2019, an estimated $1.01M.
Laurion Capital Management first reported a position in Q32 Bio in Q2 2019 and held it in 1 quarter.
Laurion Capital Management's Q32 Bio position peaked at $1.01M in Q2 2019.
80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Laurion Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.